LUNG CANCER (NON-SMALL CELL)

This study compares three treatments for lung tumors: surgery, targeted radiation (SBRT), and minimally invasive thermal ablation (using heat or cold to destroy tumors). About 100 adults with early-stage lung cancer or limited lung metastases will be followed for two years to see…

This study tests whether adding two immunotherapy drugs (cobolimab and dostarlimab) to standard chemotherapy (docetaxel) helps people with advanced non-small cell lung cancer live longer. About 758 participants whose cancer worsened after prior treatments will be randomly assigne…

This study tests whether a new combination of two drugs (belrestotug and dostarlimab) is safer and works better than the current standard treatment (pembrolizumab) for people with advanced non-small cell lung cancer that has high levels of a protein called PD-L1. About 88 adults …

This study is testing new combinations of immunotherapy drugs in people with advanced non-small cell lung cancer that has not been treated before. Participants must have high levels of a protein called PD-L1 on their tumors. The main goal is to check the safety of these drug comb…

This study tests a 12-week home-based program called Breathe Easier+ for people who have finished treatment for non-small cell lung cancer and their partners. The program includes guided walking, resistance training, and stress management delivered via smartphone or tablet. The g…

This study tests whether providing medically tailored meals and nutrition counseling can improve the diet, reduce treatment side effects, and enhance quality of life for vulnerable lung cancer patients. About 270 adults with lung cancer from diverse, low-income, or rural backgrou…

This study tests a tool called a Patient Decision Aid that helps lung cancer patients and their doctors work together to choose the right radiation dose. About 40 adults with lung tumors near the chest wall will use this tool during their consultation. The goal is to see if it in…